Previous Close | 149.45 |
Open | 150.89 |
Bid | 151.70 x 1000 |
Ask | 159.60 x 2200 |
Day's Range | 149.62 - 152.74 |
52 Week Range | 105.56 - 175.91 |
Volume | |
Avg. Volume | 7,338,458 |
Market Cap | 269.319B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 36.31 |
EPS (TTM) | 4.20 |
Earnings Date | Apr 28, 2022 - May 02, 2022 |
Forward Dividend & Yield | 5.64 (3.67%) |
Ex-Dividend Date | Apr 14, 2022 |
1y Target Est | 164.73 |
One great way to make passive income is to invest in dividend stocks. Here's why they selected AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Merck (NYSE: MRK). Keith Speights (AbbVie): Only the most elite dividend stocks become Dividend Kings.
Darden Restaurants and Kroger declared dividend increases this week. Darden Restaurants (ticker: DRI) plans to boost its quarterly dividend to $1.21 a share, a 10% increase from $1.10. Supermarket operator Kroger (KR) declared a quarterly dividend of 26 cents a share, up from 21 cents, for an increase of nearly 24%.
The FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and Novartis's (NVS) cancer combination drugs, Tafinlar (dabrafenib) + Mekinist (trametinib).